Table 1 Demography of myasthenic crisis patients
From: Hemogram parameters can predict in-hospital mortality of patients with Myasthenic crisis
MC events (n = 188) | |
|---|---|
Age at MC onset (years) | 55.59 ± 18.02 |
Sex (Female / Male) | 83 / 105 |
Underlying diseases | |
 Hypertension | 52 |
 Diabetes mellitus | 36 |
 Dyslipidemia | 7 |
 COPD | 3 |
 Liver cirrhosis | 6 |
 CRF | 7 |
Acute comorbidity | |
 AMI | 5 |
 AKI | 17 |
Medication for MG before admission | |
 None | 45 |
 Pyridostigmine only | 33 |
 DMT with or without pyridostigmine | 110 |
 Prednisolone monotherapy | 68 |
 Immunosuppressant monotherapy | 7 |
 Prednisolone + Immunosuppressant | 35 |
 PE / DFPP | 109 |
 Length of hospital stay (days) | 23.99 ± 15.64 |
During mechanical ventilation | |
 Death (≦2 weeks after intubation / >2 weeks after intubation) | 27 (20 / 7) |
After removal of endotracheal tube | |
 Mechanical venntilation > 14 days | 12 |
 Reintubation within 3 days | 16 |
 Death (≦2 weeks after extubation / >2 weeks after extubation) | 15 (9 / 6) |
 Survival at discharge | 146 |